Wednesday, September 07, 2005

Merck - Back of the Envelope Analysis

I played around with Merck's financials this morning. It appears that MRK will be able to keep paying the dividend despite major blockbuster expirations (Zocor and Fosomax) without dipping substantially into its $13 billion war chest. Here is my back of the envelope analysis (excel spreadsheet). Vitaliy N. Katsenelson, CFA This article is written for educational purposes only. It is not intended as a recommendation to buy or sell securities. Author and/or his employer may have a position in the securities discussed in this article. Security positions may change at any time.


Blogger Craig said...

Interesting blog. While I focus mostly on the technology sector, a lot of your posts are very insightful (esp. the earnings game). Best of luck with your blog.


9/14/2005 09:14:00 PM  
Blogger Craig said...

do you have a rss feed? I was going to add your blog to my newsreader, but did not notice any type of sydication/rss feeds?

9/14/2005 09:16:00 PM  

Post a Comment

<< Home